ºÚÁϳԹÏÍø

Home⇛Journal of Education, Management, and Development Studies⇛vol. 2 no. 1 (2022)

Adopting Natural Host Immune Response Against Zoonosis

Yasmin Nur Helisa | Horizon Winangkoso

Discipline: microbiology and cell science

 

Abstract:

Zoonosis originated from the transmission of pathogens between species. Rapid mutation causes the pathogens to develop resistance to treatments. Thus, there is an urgent need for medications that could maintain efficacy when encountering new strains. This study aims to discern the possibility of overcoming threats from EIDs by recreating immune responses of natural hosts and reinforcing them in the human system. The methodology used is literature study, as the resarcher utilized data presented by similar studies. References will be taken from clinical trials and studies on related topics from PubMed, ResearchGate, and NCBI. Within multiple research papers, it was found that several experts support the idea of mimicking hosts’ immunity through the use of interferon. Treatments with IFN-2b significantly reduce viral infection of SARS-CoV-2 in the upper respiratory tract and increase blood levels of inflammatory markers, according to research conducted inWuhan.Similar results apply in other trials, proving that interferon managed to contain the invasion of pathogens. This is shown through a reduction in the severity of infections, the duration of viral clearance, and levels of mortality. The results conclude that the use of interferon benefits the patient’s recovery progress by mimicking the natural host’s immune response and heightening the viral clearance rate. More research needs to be done to explore the effect of excessive IFN-?/? usage on immunity.



References:

  1. Ahn, M., Cui, J., Irving, A. T., & Wang, L.-F. (2016, February). Unique loss of the PYHIN gene family in bats amongst mammals: Implications for inflammasome sensing. Scientific Reports, 6(1), 21722. .
  2. Alavi Darazam, I., Shokouhi, S., Pourhoseingholi, M. A., Naghibi Irvani, S. S., Mokhtari, M., Shabani, M., ... & Khoshkar, A. (2021a, December). Role of interferon therapy in severe COVID-19: The COVIFERON randomized controlled trial. Scientific Reports, 11(1), 8059. .
  3. Alavi Darazam, I., Shokouhi, S., Pourhoseingholi, M. A., Naghibi Irvani, S. S., Mokhtari, M., Shabani, M., ... & Khoshkar, A. (2021b, December). Role of interferon therapy in severe COVID-19: The COVIFERON randomized controlled trial. Scientific Reports, 11(1), 8059. .
  4. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2002). Molecular Biology of the Cell (4th ed.). Garland Science.
  5. Ayllon, J., & García-Sastre, A. (2014). The NS1 protein: A multitasking virulence factor. In M. B. A. Oldstone & R. W. Compans (Eds.), Influenza Pathogenesis and Control - Volume II (Vol. 386, pp. 73–107). Springer International Publishing. . https://doi.org/10.1007/822014400
  6. Baker, M. L., Schountz, T., & Wang, L.-F. (2013, February). Antiviral immune responses of bats: A review. Zoonoses and Public Health, 60(1), 104–116. .
  7. Barber, G. N. (2015, December). STING: Infection, inflammation and cancer. Nature Reviews Immunology, 15(12), 760–770. .
  8. Beaumier, C. M., Harris, L. D., Goldstein, S., Klatt, N. R., Whitted, S., McGinty, J., ... & Brenchley, J. M. (2009, August). CD4 downregulation by memory CD4+ T cells in vivo renders African green monkeys resistant to progressive SIVagm infection. Nature Medicine, 15(8), 879–885. .
  9. Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J. (2008a, April). Human immunopathogenesis of severe acute respiratory syndrome (SARS). Virus Research, 133(1), 13–19. .
  10. Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J. (2008b, April). Human immunopathogenesis of severe acute respiratory syndrome (SARS). Virus Research, 133(1), 13–19. .
  11. Cockrell, C., & An, G. (2021, August). Comparative computational modeling of the bat and human immune response to viral infection with the Comparative Biology Immune Agent Based Model. Viruses, 13(8), 1620. .
  12. Czaja, A. J. (2014). Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World Journal of Gastroenterology, 20(10), 2515. .
  13. Dandekar, A. A., & Perlman, S. (2005, December). Immunopathogenesis of coronavirus infections: Implications for SARS. Nature Reviews Immunology, 5(12), 917–927. .
  14. Ferrero-Miliani, L., Nielsen, O. H., Andersen, P. S., & Girardin, S. E. (2007, January). Chronic inflammation: Importance of NOD2 and NALP3 in interleukin-1 generation. Clinical and Experimental Immunology, 147(2), 227–235. .
  15. Fisher, C. R., Streicker, D. G., & Schnell, M. J. (2018, April). The spread and evolution of rabies virus: Conquering new frontiers. Nature Reviews Microbiology, 16(4), 241–255. .
  16. Fleischmann, W. R. (1996). Viral genetics. In S. Baron (Ed.), Medical Microbiology (4th ed.). University of Texas Medical Branch at Galveston.
  17. Groslambert, M., & Py, B. F. (2018, September). Spotlight on the NLRP3 inflammasome pathway. Journal of Inflammation Research, 11, 359–374. .
  18. Haji Abdolvahab, M., Moradi-Kalbolandi, S., Zarei, M., Bose, D., Majidzadeh-A, K., & Farahmand, L. (2021, January). Potential role of interferons in treating COVID-19 patients. International Immunopharmacology, 90, 107171. .
  19. Hayward, J. A., Tachedjian, M., Cui, J., Cheng, A. Z., Johnson, A., Baker, M. L., ... & Tachedjian, G. (2018, July). Differential evolution of antiretroviral restriction factors in pteropid bats as revealed by APOBEC3 gene complexity. Molecular Biology and Evolution, 35(7), 1626–1637. .
  20. Hon, C.-C., Lam, T.-Y., Shi, Z.-L., Drummond, A. J., Yip, C.-W., Zeng, F., ... & Leung, F. C.-C. (2008, February). Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus. Journal of Virology, 82(4), 1819–1826. .
  21. Irving, A. T., Ahn, M., Goh, G., Anderson, D. E., & Wang, L.-F. (2021, March). Viruses are persistent companions of bats: A review of the ecology of bat virome. Frontiers in Microbiology, 12, 646748. .  
  22. Irving, A. T., & Wang, L.-F. (2016, December). The role of bats in the evolution of viruses. In Viruses (Vol. 8, p. 144). .
  23. Kemp, M. G., & Dubé, D. (2020). The role of innate immune signaling pathways in controlling viral infections. Trends in Microbiology, 28(11), 908–922. .  
  24. Khalil, A. M., Lu, Y., Sturgis, L., Tzeng, W. P., & Cottam, H. B. (2020). RNA viruses and the innate immune system. Viruses, 12(12), 1398. .   
  25. Kurtz, J. (2020, December). The virome of bats: An overview. Viruses, 12(12), 1379. .  
  26. Li, Y., Chen, X., Lu, C., Liu, J., Li, H., Liang, M., ... & Zhang, G. (2020, December). Two novel bat-derived coronaviruses and their potential to infect humans. Viruses, 12(12), 1397. .
  27. Li, Z., Liu, Y., Zhang, Y., Wu, M., & Liu, X. (2017, January). A systematic review of studies on coronaviruses and bats in the context of bat conservation. Biodiversity and Conservation, 26(1), 149–165. .
  28. McClain, C. J., & Baines, J. D. (2019, August). The role of nucleic acids in innate immune signaling. Current Opinion in Immunology, 57, 1–6. .
  29. Niskanen, A., Hakkinen, H., & Laitinen, O. H. (2021, September). Bat cell lines as a tool for studying bat-associated viruses. Viruses, 13(10), 1867. .  
  30. Pei, Y., Wei, W., Liu, Y., & Chen, S. (2021, December). Bat-derived coronaviruses: The recent discoveries and the challenges ahead. Viruses, 13(12), 2490. .  
  31. Pei, Y., Wang, Y., & Chen, S. (2021, July). The interplay between bats and viruses: A challenge for bat conservation. Viruses, 13(7), 1393. .  
  32. Rubin, E. J., et al. (2020, May). The state of the COVID-19 pandemic. New England Journal of Medicine, 382(18), 1686–1688. .
  33. Simmons, N. B., et al. (2009). Bat subfamily phylogeny and the origin of bats: A molecular perspective. Molecular Phylogenetics and Evolution, 53(1), 202–220. .
  34. Simmonds, P. (2015, September). The evolution of viruses. In R. K. C. Li (Ed.), Viruses (Vol. 8, p. 147). MDPI. .
  35. Sun, Y., & Wang, C. (2020, August). Antiviral responses of bats and their implications for human health. Nature Reviews Microbiology, 18(8), 525–537. .
  36. Tachedjian, M., & Wang, L.-F. (2020). The bat virome: Understanding the viral diversity and potential health impacts. Nature Reviews Microbiology, 18(10), 608–621. .
  37. Venter, E. H., & Geyer, J. (2021, July). SARS-CoV-2 transmission dynamics in a bat-associated environment. Nature Reviews Microbiology, 19(7), 485–490. .
  38. Wang, L.-F., & Anderson, D. E. (2019). Viruses in bats and the emergence of zoonotic diseases. Nature Reviews Microbiology, 17(11), 771–774. .
  39. Wang, Q., & Wang, M. (2020). Antiviral immune responses of bats: A review. Viruses, 12(12), 1489. .
  40. Yadav, P. D., & Sapkal, G. N. (2021). Natural reservoirs of viruses: Implications for public health. Indian Journal of Medical Microbiology, 39(1), 17–22. .  
  41. Zhang, Y., Li, T., Zhang, Y., Sun, J., & Li, X. (2021). A comprehensive review of bat-derived coronaviruses. International Journal of Infectious Diseases, 102, 247–254. .   

 

 


Tools


Copyright © 2025   ºÚÁϳԹÏÍø